Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)

Mario de la Fuente Revenga; Daisuke Ibi; Travis Cuddy; Rudy Toneatti; Mitsumasa Kurita; Maryum K. Ijaz; Michael F. Miles; Jennifer T. Wolstenholme; Javier González-Maeso

doi:10.1038/s41386-018-0255-x

Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)

Mario de la Fuente Revenga
, Daisuke Ibi
, Travis Cuddy
, Rudy Toneatti
, Mitsumasa Kurita
, Maryum K. Ijaz
, Michael F. Miles
, Jennifer T. Wolstenholme
, Javier González-Maeso

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Following the publication of this article Figs. 3b, c were published incorrectly. Also in sub-panel c of Fig. 4, ‘Chronic cloza ine’ should read ‘Chronic clozapine’. (Figure presented.).

Original language	English
Pages (from-to)	455-456
Number of pages	2
Journal	Neuropsychopharmacology
Volume	44
Issue number	2
DOIs	https://doi.org/10.1038/s41386-018-0255-x
State	Published - 1 Jan 2019

Access to Document

10.1038/s41386-018-0255-x

Fingerprint

Dive into the research topics of 'Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)'. Together they form a unique fingerprint.

Cite this

de la Fuente Revenga, M., Ibi, D., Cuddy, T., Toneatti, R., Kurita, M., Ijaz, M. K., Miles, M. F., Wolstenholme, J. T., & González-Maeso, J. (2019). Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4). Neuropsychopharmacology, 44(2), 455-456. https://doi.org/10.1038/s41386-018-0255-x

@article{7af2411647574938b8d10289aa649103,

title = "Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)",

abstract = "Following the publication of this article Figs. 3b, c were published incorrectly. Also in sub-panel c of Fig. 4, {\textquoteleft}Chronic cloza ine{\textquoteright} should read {\textquoteleft}Chronic clozapine{\textquoteright}. (Figure presented.).",

author = "\{de la Fuente Revenga\}, Mario and Daisuke Ibi and Travis Cuddy and Rudy Toneatti and Mitsumasa Kurita and Ijaz, \{Maryum K.\} and Miles, \{Michael F.\} and Wolstenholme, \{Jennifer T.\} and Javier Gonz{\'a}lez-Maeso",

note = "Publisher Copyright: {\textcopyright} 2018, American College of Neuropsychopharmacology.",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41386-018-0255-x",

language = "English",

volume = "44",

pages = "455--456",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Springer Nature",

number = "2",

}

de la Fuente Revenga, M, Ibi, D, Cuddy, T, Toneatti, R, Kurita, M, Ijaz, MK, Miles, MF, Wolstenholme, JT & González-Maeso, J 2019, 'Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)', Neuropsychopharmacology, vol. 44, no. 2, pp. 455-456. https://doi.org/10.1038/s41386-018-0255-x

Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4). / de la Fuente Revenga, Mario; Ibi, Daisuke; Cuddy, Travis et al.
In: Neuropsychopharmacology, Vol. 44, No. 2, 01.01.2019, p. 455-456.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4)

AU - de la Fuente Revenga, Mario

AU - Ibi, Daisuke

AU - Cuddy, Travis

AU - Toneatti, Rudy

AU - Kurita, Mitsumasa

AU - Ijaz, Maryum K.

AU - Miles, Michael F.

AU - Wolstenholme, Jennifer T.

AU - González-Maeso, Javier

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Following the publication of this article Figs. 3b, c were published incorrectly. Also in sub-panel c of Fig. 4, ‘Chronic cloza ine’ should read ‘Chronic clozapine’. (Figure presented.).

AB - Following the publication of this article Figs. 3b, c were published incorrectly. Also in sub-panel c of Fig. 4, ‘Chronic cloza ine’ should read ‘Chronic clozapine’. (Figure presented.).

UR - https://www.scopus.com/pages/publications/85058843649

U2 - 10.1038/s41386-018-0255-x

DO - 10.1038/s41386-018-0255-x

M3 - Comment/debate

C2 - 30401942

AN - SCOPUS:85058843649

SN - 0893-133X

VL - 44

SP - 455

EP - 456

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 2

ER -

de la Fuente Revenga M, Ibi D, Cuddy T, Toneatti R, Kurita M, Ijaz MK et al. Correction to: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity (Neuropsychopharmacology, (2019), 44, 2, (443-454), 10.1038/s41386-018-0143-4). Neuropsychopharmacology. 2019 Jan 1;44(2):455-456. doi: 10.1038/s41386-018-0255-x